📋 Tender Overview
Contract awarded for The acquisition of medicines various national programs lot-0082, title: -atezolizumab 1200 mg, description: see annex 1 lot-0132, title: -obinutuzumab 1000 mg, description: see annex 1 lot-0144, title: -pertuzumab 420 mg, description: see annex 1 lot-0145, title: -polatuzumab vedotin 30 mg, description: see annex 1 lot-0146, title: -polatuzumab vedotin 140 mg, description: see annex 1 lot-0158, title: -trastuzumab emtansin 100 mg, description: see annex 1 lot-0159, title: -trastuzumab emtansin 160 mg, description: see annex 1 lot-0167, title: -atezolizumab 1200 mg cost volume, description: see annex 1 lot-0184, title: -ocrelizumab 300mg, description: see annex 1 estimated value excluding vat: 784281.96 ron.The acquisition of medicines various national programs